Silence Therapeutics (SLN) Revenue (2024 - 2026)
Silence Therapeutics (SLN) reported Revenue of $422000.0 for Q1 2026, up 197.18% on a YoY basis from $142000.0 in Q1 2025, and up 1141.18% sequentially from $34000.0 in Q4 2025.
Silence Therapeutics (SLN) Revenue (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Revenue data on file, last reported at $422000.0 in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 197.18% year-over-year to $422000.0; the trailing twelve-month figure through Mar 2026 stood at $839000.0 (down 96.98% YoY), and the FY2025 full-year result was $559000.0, down 98.71% from the prior year.
- Revenue grew to $422000.0 in Q1 2026, from $34000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $25.3 million in Q4 2024 to a low of $34000.0 in Q4 2025.
- A 3-year average of $4.9 million and a median of $422000.0 in 2026 frame the typical range for Revenue.
- Across the five-year window, Revenue slumped 99.87% in 2025 and soared 197.18% in 2026, its largest moves.
- Tracing SLN's Revenue over 3 years: stood at $25.3 million in 2024, then tumbled by 99.87% to $34000.0 in 2025, then jumped by 1141.18% to $422000.0 in 2026.
- Business Quant data shows SLN's Revenue at $422000.0 in Q1 2026, $34000.0 in Q4 2025, and $159000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Silence Therapeutics | 1.59 Bn | 1.45 Bn | 411,000.00 | 422,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 422,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 142,000.00 |
| Dec 31, 2024 | 25.31 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 15.70 Mn |